Effect of maternal multimorbidity on the risk of preterm birth: Record-linkage study

Amaya AZCOAGA-LORENZO, Adeniyi Francis FAGBAMIGBE, Utkarsh AGRAWAL, Siang Ing LEE, Mairead BLACK, Jonathan Kennedy, Holly Hope, Anuradhaa SUBRAMANIAN, Astha ANAND, Beck TAYLOR, Christine Damase-Michel, Kelly-Ann EASTWOOD, Christopher YAU, Francesca CROWE, Gillian SANTORELLI, Maria Loane, Zoe VOWLES, Ngawai MOSS, Peter BROCKLEHURST, Rachel PLACHCINSKIShakila THANGARATINAM, Dermot O’Reilly, Kathryn M ABEL, Sinead BROPHY, Colin McCOWAN, Krishnarajah NIRANTHARAKUMAR

Research output: Contribution to journalSpecial issue

Abstract

Objective: One in five pregnant women and birthing people lives with multiple long-term health conditions (multimor-bidity). Preterm birth is a leading cause of neonatal morbid-ity and mortality. In this study, which is part of the larger MuM-PreDiCT Consortium research programme, we aimed to quantify the association between maternal multimorbid-ity and preterm birth in pregnant women and birthing peo-ple in Tayside and Fife (Scotland).

Method: Population-based observational record-linkage study using the Maternity Inpatient and Day Case – Scottish Morbidity Record (SMR02). All pregnancies identified from women aged 15–49 years with a recorded or esti-mated conception date between 1st January 2014 and 31st of December 2018 in Tayside and Fife regions were included. Multimorbidity (MM) was defined based on the presence of two or more pre-existing long-term conditions prior to each pregnancy. A list of 79 health conditions, previously approved by the MuM-PreDiCT consortium using the International Classification of Disease 10th version (ICD-10 codes) and community prescriptions, was used. Babies born <37 weeks of gestation were classified as preterm. A multiple regression analysis was conducted. The overall proportion of preterm births by MM with 95% CI is reported.

Results: 26 328 singleton births were identified during the study period. Of which 2614 (9.9%) were preterm. Of these, 1991 (76.2%) infants were born to women with no identified MM and 623 (23.8%) to women with MM. The prevalence of preterm among mothers with MM and without MM are 14.4% vs. 9.1% (<37 weeks); 9.9% vs. 5.5 % (32– <37 weeks) 1.0% vs. 0.7% (28–32 weeks) and 3.4% vs. 2.9% (<28 weeks). When adjusted for age , MM was significantly associated with preterm birth <37 weeks aOR = 1.67 (95% CI 1.51–1.84), 32– <37 weeks aOR = 1.89(95% CI 1.68–2.12); 28–32 weeks aOR = 1.48(95% CI 1.06–2.07) and <28 weeks aOR = 1.16(95% CI 0.96 – 1.39).

Conclusions: Multimorbidity at the time of conception was associated with an increased risk of preterm birth. Multimorbidity presents a significant health burden to women and their offspring. Routine and comprehensive evaluation of women with multimorbidity during pregnancy is needed as our findings suggest significant associations with adverse birth outcomes.
Original languageEnglish
Article numberE P. 0 5 51
Pages (from-to)10
Number of pages1
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume129
Issue numberS1
DOIs
Publication statusPublished - 10 Jun 2022
EventRoyal College of Obstretricians & Gynaecologists World Congress -
Duration: 13 Jun 202215 Jun 2022
https://www.rcog.org.uk/congress2022

Fingerprint

Dive into the research topics of 'Effect of maternal multimorbidity on the risk of preterm birth: Record-linkage study'. Together they form a unique fingerprint.

Cite this